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Abstract
Intravenous delivery of human adipose-derived stromal cells (hASCs) is a promising option for the treatment of ischemia.
After delivery, hASCs that reside and persist in the injured extravascular space have been shown to aid recovery of tissue
perfusion and function, although low rates of incorporation currently limit the safety and efficacy of these therapies. We
submit that a better understanding of the trafficking of therapeutic hASCs through the microcirculation is needed to
address this and that selective control over their homing (organ- and injury-specific) may be possible by targeting
bottlenecks in the homing process. This process, however, is incredibly complex, which merited the use of computational
techniques to speed the rate of discovery. We developed a multicell agent-based model (ABM) of hASC trafficking during
acute skeletal muscle ischemia, based on over 150 literature-based rules instituted in Netlogo and MatLab software
programs. In silico, trafficking phenomena within cell populations emerged as a result of the dynamic interactions between
adhesion molecule expression, chemokine secretion, integrin affinity states, hemodynamics and microvascular network
architectures. As verification, the model reasonably reproduced key aspects of ischemia and trafficking behavior including
increases in wall shear stress, upregulation of key cellular adhesion molecules expressed on injured endothelium, increased
secretion of inflammatory chemokines and cytokines, quantified levels of monocyte extravasation in selectin knockouts, and
circulating monocyte rolling distances. Successful ABM verification prompted us to conduct a series of systematic knockouts
in silico aimed at identifying the most critical parameters mediating hASC trafficking. Simulations predicted the necessity of
an unknown selectin-binding molecule to achieve hASC extravasation, in addition to any rolling behavior mediated by hASC
surface expression of CD15s, CD34, CD62e, CD62p, or CD65. In vitro experiments confirmed this prediction; a subpopulation
of hASCs slowly rolled on immobilized P-selectin at speeds as low as 2 mm/s. Thus, our work led to a fundamentally new
understanding of hASC biology, which may have important therapeutic implications.
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Introduction
Intravenous (i.v.) delivery of therapeutic stem cells is a
promising option for the treatment of ischemic injuries.
Therapeutic cells that reside and persist (i.e., incorporate) in
the injured extravascular space have been shown to aid recovery
of tissue perfusion and function, although low rates of
incorporation currently limit the safety and efficacy of these
therapies [1]. It follows that methods to increase the number of
incorporated cells may lead to better clinical outcomes. To
achieve this, we submit that a better understanding of stem cell
trafficking through the microvasculature prior to incorporation is
necessary and that computational modeling techniques could
speed the rate of discovery; current investigations however are
hampered by the processes’ inherent complexity. Towards this
end, we present an agent-based computational model (ABM) of
therapeutic stem cell trafficking during skeletal muscle ischemia
that is capable of generating new hypotheses quickly and cost-
effectively.
The process by which endogenous circulating cells traffic to sites
of general injury and gain access to the extravascular tissue space is
referred to as the adhesion cascade [2]. Most often studied in
leukocyte subpopulations (e.g., neutrophils and monocytes), it is
applicable to the mobilization of circulating stem cells to sites of
injury [3]. Depicted in Figure 1, the adhesion cascade consists of a
series of sequential events including margination, rolling, integrin
activation, firm adhesion, and trans-endothelial migration (extrav-
asation). This complex process is mediated by the interplay
between cellular adhesion molecule (CAM) expression, chemo-
kines and cytokines, and hemodynamics [4–14].
During skeletal muscle ischemia, tissue damage and dysfunction
results from decreases in a tissue’s blood supply if nutrient and
oxygen delivery cannot meet metabolic demand. As the blood
supply decreases, reductions in blood volume flow rates through
the downstream vasculature lead to reduced wall shear stresses
(WSS), blood flow velocities, and hydrostatic pressures. Converse-
ly, arterial and collateral vessels up-stream of the ligation
experience increases in blood volume flow rates, as blood flow is
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increases in WSS and hydrostatic pressures) [15].
Altered blood flow profiles activate endothelial and perivascular
cells through changes in WSS and circumferential stress,
respectively, which initiate a complex cascade of events to
mobilize circulating cells to the site of injury. Activated endothelial
cells (ECs) increase their surface expression of key CAMs,
including the selectins (e.g., E-selectin and P-selectin) to support
rolling, and the integrins to support firm adhesion and
extravasation of circulating cells to the endothelium [15]. The
major integrin receptors preferentially expressed on ischemic
endothelium include vascular cell adhesion molecule-1 (VCAM-1)
and intracellular adhesion molecule-1 (ICAM-1). In concert,
activated ECs and perivascular cells also secrete numerous growth
factors, chemokines, and cytokines, such as monocyte chemoat-
tractant protein-1 (MCP-1), tumor necrosis factor-a (TNF-a), and
interleukin-1b (IL-1b) to increase binding affinities and ensure a
higher probability of circulating cell adhesion to the endothelium
[16]. Through these mechanisms and others, circulating cells are
able to home to ischemic injury sites, adhere to the endothelium,
extravasate, and incorporate into the injured tissue.
This paper focuses on therapeutically delivered stem cell
populations, or cells that are injected i.v. in order to repair or
regenerate injured tissues. It has been hypothesized that i.v.-
injected stem cells adhere to activated endothelium using
mechanisms that are similar to those of endogenous leukocytes.
Moreover, it has been proposed that these adhesive interactions
are rate-limiting for an effective therapeutic response [1]. We have
chosen to investigate hASCs primarily for their widespread
availability and potential clinical impact. Similar to other stem
cell populations, hASCs are characterized by a high proliferation
and differentiation potential [17] and express many known stem
cell-associated markers [18,19]. They are isolated from adipose
tissue following routine intra-operative suction lipectomy or
Figure 1. Graphical representation of the adhesion cascade during acute skeletal muscle ischemia, as instituted in the ABM. The
adhesion cascade generally proceeds sequentially before incorporation, and is mediated by the interplay between adhesion molecule expression,
chemokines and cytokines, hemodynamics, and survey behavior. Interactions are complex spatially and temporally, and cell phenotypes accounted
for within simulations are tissue macrophages, endothelial cells making up the blood vessel wall, circulating monocytes, and circulating human
adipose-derived stromal cells.
doi:10.1371/journal.pcbi.1000294.g001
Author Summary
Ischemic pathologies, such as acute myocardial infarction
and peripheral vascular disease, continue to be associated
with high morbidities and mortalities. Recently, therapies
wherein adult stem cells are injected into the circulation
have been shown to increase blood flow and help to
restore tissue function following injury. Pre-clinical animal
models and human trials have shown successes utilizing
this approach, but variable trafficking efficiencies and low
incorporation of cells into the injured tissue severely limit
effectiveness and may preclude clinical adoption. To
address this, we sought to study the complex process of
how injected stem cells traffic through the microcircula-
tion and home to sites of injury, in an effort to identify
bottlenecks in this process that could be manipulated for
therapeutic gain. We developed an agent-based computer
model to speed the rate of discovery, and we identified a
key cell–cell adhesion interaction that could be targeted to
enhance stem cell homing efficiencies during injectable
stem cell therapies.
ABM of Stem Cell Homing
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restoring perfusion to ischemic tissue following i.v. delivery
[20,21]. hASC homing and trafficking capabilities [22], however,
are relatively under-studied, and this paper presents a novel
computational platform for investigation into this important, but
currently ambiguous research area.
We utilized ABM techniques to interrogate therapeutic hASC
trafficking during ischemia. Adopting an agent-oriented approach
to study the stem cell-specific adhesion cascade has been proposed
previously by us [23] and others [24,25]. Here, we expanded the
scope of our prior ABM of monocyte trafficking in healthy skeletal
muscle microvasculature to include therapeutically delivered stem
cells, tissue-resident macrophages, circulating monocytes, endo-
thelial cells, ischemic injury, and a larger microvascular network.
The adhesion cascade was simplified to three primary parameters:
CAM expression, hemodynamic forces, and chemokine and
cytokine secretion and exposure. A network blood flow analysis
program [26], instituted in MATLAB, calculated pressure, flow
velocities, and wall shear stresses within the simulated microvas-
cular network, while the other parameters were governed in the
Netlogo software program [27] by over 150 rules derived from
independent peer-reviewed literature (Text S1).
Model verification was performed by comparing simulation results
to data from independent peer-reviewed literature including: (1)
monocytes’ ability to extravasate independent of selectin-mediated
rolling; (2) the preferential upregulation of endothelial CAMs
implicated in circulating cell adhesion; (3) the increased secretion of
inflammatorychemokinesandcytokinesbyischemicendothelium;(4)
increased WSS and network flow rates in collateral microvascular
networks; and (5) rolling distances of circulating monocytes.
Following model verification, the i.v. delivery of therapeutic
hASCs was simulated. Early simulations showed unexpected levels
of hASC extravasation, which prompted a re-examination of the
rule-set and the formulation and testing of a new hypothesis.
Rolling via the selectins has been shown to be critical for the
homing of other circulating cell populations and is the rate-limiting
step during neutrophil trafficking [2,28]. hASCs do not possess the
dominant ligand for the selectins (P-selectin glycoprotein ligand-1
(PSGL-1)), but we hypothesized that they were able to roll on
selectins independent of PSGL-1 expression and that this may be a
rate-limiting step, as well. Systematic knockout experiments in silico
supported this hypothesis, and we subsequently validated our
model predictions in vitro in parallel plate flow chamber assays. In
this way, the model was used as a tool and led to new
understandings after it behaved unexpectedly. Furthermore, the
work suggests that selectin interactions are an important mediator
of therapeutic hASC trafficking.
This work is particularly illustrative of the power and benefit of
agent-based modeling in biology. When one examines or studies a
biological phenomenon, it is necessary to determine the essential
parameters, species, molecules, and behaviors that are necessary or
sufficient to account for that phenomenon. Agent-based models can
help to formalize this process, and ABMs, like all models (including
conceptual models), are necessarily incomplete. Nonetheless, their
use helps facilitate rapid discovery; model-aided hypothesis gener-
ation provides a systematic means of determining the next steps in
the discovery process by identifying what constitutes ‘‘sufficient’’.
Results
Model Verification: ABM Reproduces Key Aspects of
Monocyte Trafficking and Ischemia
Two scales of biological organization were present within the
model: (1) the cellular-scale encoded at the level of literature-based
agent rules (Text S1); and (2) the tissue-level scale represented by
the overall model, which was not explicitly programmed and
whose observables represent global measurements. Model verifi-
cation was performed by examining higher order system behaviors
(tissue-level scale) and comparing them to corresponding tissue-
level measurements from independent wet-lab experimentation.
This is, in effect, a test of the effectiveness of the translation of
knowledge between the two scales that existed in the model [29].
Specifically, the model was verified by examining both
monocyte trafficking ability and key aspects of acute skeletal
muscle ischemia, prior to conducting simulations of hASC
trafficking. The model reproduced three properties of ischemic
injuries including: (1) increases in WSS and network flow rates; (2)
up-regulation of key CAM expressed by injured endothelium; and
(3) increased secretion of chemokines and cytokines. Similarly, two
properties of monocytes were reproduced in silico including their
independence from selectin-mediated rolling and their average
rolling distances during trafficking. These higher order system
behaviors were the aggregate result of thousands of interactions
between individual agents, their neighbors, and their local
environment as they responded to separate dynamic cues outlined
in the literature-based rule-sets (cellular-scale).
Ischemic injury was simulated by increasing the pressure at the
feeding arteriole by 25%, after which resultant hemodynamic
properties were re-calculated (Table 1). Network flow rates were
elevated 17%, and average WSS was elevated in arterioles (187%),
capillaries (177%), and venules (48%). These hemodynamic
changes are characteristic of a collateral microvascular network
(adjacent to an injured network) during acute skeletal muscle
ischemia. This portion of the network represents one that remains
patent following injury and would be capable of supporting the
trafficking and extravasation of circulating therapeutic cells (i.e.,
we are not simulating the vessels downstream of an obstruction
that would receive decreased or no blood flow).
During acute skeletal muscle ischemia in vivo, P-selectin, E-
selectin, VCAM-1, and ICAM-1 are upregulated on the luminal
vessel wall of the endothelium. In our ABM, all of these CAMs
were upregulated by EC agents after the simulated ischemic injury
(injury induced at time=300 seconds). Extravasation of simulated
monocytes gradually increased throughout the simulations as
increased CAM expression facilitated increased extravasation
(Figure 2). Adhesion molecule expression prior to the simulation
of the ischemic injury (time=0–300 seconds) was relatively stable,
as expected, and remained stable indefinitely in the absence of an
ischemic event (data not shown). Specifically, simulations in
‘‘healthy microvascular networks’’ were performed for 2,400 sec-
onds with and without simulated hASC populations.
Acute ischemic injuries are characterized by alterations in
circulating chemokine and cytokine levels in animal models and in
humans. Implicated chemokines and cytokines during vascular
injury include stromal cell-derived factor-1alpha (SDF-1a),
interleukin-1beta (IL-1b), interleukin-8 (IL-8), interleukin-10 (IL-
10), monocyte chemoattractant protein-1 (MCP-1), tumor necrosis
factor-alpha (TNF-a), transforming growth factor-beta (TGF-b),
and nitric oxide (NO), which formed the basis for their inclusion in
the rule-sets [4,5,30] (Text S1). In ABM simulations, the secretion
of inflammatory chemokines and cytokines by ECs was increased
(Figure 3). Furthermore, circulating monocytes were increasingly
exposed to circulating chemokines and cytokines (Figure 4), as
expected. Unfortunately, in vivo data for the absolute amount of
inflammatory chemokines and cytokines being secreted by ECs
during ischemia is inconsistently reported in the literature, and so
it could not serve as comparison here. Rather, their increased
(relative) presence serves as verification (Text S1).
ABM of Stem Cell Homing
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was shown to be unaffected in E-selectin knockouts, P-selectin
knockouts, and only marginally in double selectin knockouts (10%
decrease). Triple-selectin knockouts virtually eliminated instances
of rolling and extravasation (78% reduction; Figure 5). This agrees
with experimental literature showing that monocytes are able to
proceed through the adhesion cascade non-sequentially and
incorporate into extravascular spaces without rolling on the
selectins prior to firm adhesion (Table 2). Simulating a knockout of
ICAM-1 significantly inhibited monocyte extravasation (55%
reduction; Table 2), and it appears that rolling behavior was
affected, as well (Figure 5). Average monocyte rolling distances
ranged from 72.6614.7 to 198657.5 mm in injured and healthy
tissue, respectively. The rolling distances of monocytes that
eventually extravasated did not significantly differ from that of
monocytes that failed to extravasate, in either healthy or ischemic
tissue (Figure 6). In vivo, leukocyte rolling distances have been
reported to range from 30–400 mm (Table 2).
Model Prediction: hASCs Require Unknown Selectin-
Binding Molecule for Extravasation In Silico
Within the rule-set, adhesion molecule expression for CD15s,
CD34, CD65, E-selectin (CD62e), P-selectin (CD62p), L-selectin
(CD62L) and PSGL-1 (CD162) were included for hASC
populations (Table 3 and Text S1) because these molecules have
all been shown or proposed to support selectin-mediated rolling.
Based on independent in vivo experiments wherein hASCs were
delivered intravenously to ischemic mouse hindlimbs and a review
of relevant stem cell literature (Text S1), we expected the efficiency
of hASC incorporation into ischemic tissue to be approximately
10% of the total cells delivered, which would also be 3–56that of
levels quantified in non-ischemic tissue. Simulations of hASC
trafficking to non-ischemic tissue produced an incorporation
efficiency of 1.3860.43% (i.e., approximately 1–2% of the total
injected circulating cells extravasated into the injured extravascu-
lar space). Therefore, we anticipated simulations of hASC
trafficking to ischemic tissue to produce an incorporation
efficiency of 3–10% in silico. The rule-sets, as instituted in
prototype models, however failed to reproduce this in silico;
incorporation efficiency was less than 5% (4.4960.88; Figure 7)
and thus at the lower-end of expected values.
This inconsistency indicated that there likely existed an
additional adhesion molecule in vivo that was not accounted for
by the rules in our initial ABM. We hypothesized that an unknown
selectin-binding molecule, similar to PSGL-1, could account for
this disparity, and conducted simulations to test this hypothesis by
including additional rules in the ABM rule-set. Rules for the
hypothesized CAM, termed ‘‘selectin binding molecule-X’’ or
SBM-X, included the ability to bind all of the selectins and a 75%
probability of expression by hASCs (Text S1). This increased the
simulated levels of hASC extravasation to 8.961.47% of those
delivered (Figure 7), which was in the`expected range. Conversely,
knocking out CD34 expression on circulating hASCs in silico had
no significant effect on extravasation in ischemic tissue (Figure 7),
nor did knocking out SBM-X expression on circulating hASCs
have a statistically significant effect in healthy tissue (data not
shown). Our ABM simulations, therefore, predicted the necessity
and ability of therapeutically delivered hASCs to roll on the
selectins, independent of PSGL-1.
Model Validation: hASCs Slowly Roll on Immobilized
P-Selectin In Vitro
The ABM simulations predicted the importance of selectin-
mediated rolling for hASC trafficking (Figure 7), despite the fact
that hASCs do not express the main ligand for the selectins,
PSGL-1. This hypothesis was tested in vitro using a parallel plate
flow chamber. In the laminar flow assay, where hASCs were
perfused over substrates containing immobilized P-selectin, a small
percentage of hASCs (,1%) were observed interacting with and
slowly rolling on immobilized P-selectin. Rolling speeds as low as
2 mm/s were quantified at two levels of WSS (0.5 dyne/cm
2 and
1.0 dyne/cm
2) (Figure 8) and were below that measured for the
negative controls (Tween 20 for non-specific adhesion; Fc IgG for
human IgG control) and below 20% of the free-stream velocity.
The incubation of hASCs with competitive antibodies to PSGL-1
had no effect on hASC rolling speeds (white squares). However,
incubating substrates with competitive antibodies to P-selectin
eliminated instances of rolling (data not shown), thus confirming
that rolling in this assay was mediated by the immobilized P-
selectin. Results were consistent across multiple donors and
passages (Figure 8). Plots of the instantaneous speeds of rolling
hASCs (Figure 9) were typical of rolling leukocytes [31],
specifically the characteristic stop-and-go behavior.
Molecular Mechanism: Surface Expression of CD24 by
hASCs
Flow cytometry analysis showed positive surface expression of
CD24 by early, middle, and late-passage hASCs (Table 4).
Expression was variable and may have been a function of donor
and/or passage number. Pooling all data, mean expression level
was 6.6566.7% positive (min=0.77%, max=21.1%). Selectin-
mediated rolling via CD24 has been shown to occur in other cell
Table 1. Ischemic injury in a downstream collateral
microvascular network was simulated by increasing the
pressure at the feeder arteriole by 25%.
In Silico Network Parameter Healthy Ischemic Change
Pressure (mmHg)
1 inlet 20 25 25%
5 outlets (mean, min, max) (16.8, 15, 18) (16.8, 15, 18) na
Network flow (ml/min) 31.3669 36.6670 17%
Shear stress (dynes/cm
2)
Arteriole (avg) 1.3561.2 3.8963.6 187%
Capillary (avg) 0.9160.5 2.5161.4 177%
Venule (avg) 1.4261.3 2.1162.0 48%
Location Skeletal
muscle
Collateral
network
na
Area (mm
2) 11.02 11.02 na
Dimensions (mm) 4.6962.34 4.6962.34 na
Vessel length per mm
2
Arteriole 0.91 0.91 na
Capillary 2.78 2.78 na
Venule 3.26 3.26 na
Vessel diameter (mm)
Arteriole 10.865.05 10.865.05 na
Capillary 6.561.83 6.561.83 na
Venule 12.967.81 12.967.81 na
The resultant changes in hemodynamic parameters are characteristic of acute
ischemic injury in skeletal muscle.
doi:10.1371/journal.pcbi.1000294.t001
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population, although constitutive CD24 gene expression has been
previously reported [32].
Discussion
A better understanding of the homing processes used by
therapeutic cells will lead to the development of new and more
effective cell-based therapies. For example, the identification of a
bottleneck in the adhesion cascade could inform molecular
targeting strategies to increase trafficking efficiencies of hASCs
following their i.v. delivery during treatment of ischemic injury.
And with this study, we now know that approximately 1% of
hASCs are capable of slowly rolling on P-selectin, which may limit
their homing in pre-clinical studies. Furthermore, this 1% may
account for the majority of the cells that are able to successfully
home in vivo, in which case methods to enhance these P-selectin
adhesive interactions should be developed.
These findings need to be verified in vivo and their mechanisms
of action more clearly elucidated before new therapies can be
developed. The development of this and other strategies, however,
has been hampered by the complexity of circulating cell homing
and the field’s incomplete understanding of governing mecha-
nisms. It is true that detailed mechanistic data on the leukocyte
adhesion cascade is available, but it is still unclear if the same
governing principles universally apply to circulating hASCs. This
combined with the fact that investigation of all relevant parameters
individually in vitro was not immediately feasible (time and
resource-prohibitive), prompted us to undertake a computational
approach in our study of hASC homing.
We developed an ABM of acute skeletal muscle ischemia and
simulated the therapeutic delivery of hASCs. For model
verification, we performed a series of in silico knockout experi-
ments. Data indicated a prominent role for ICAM-1 in adhesion
and extravasation of monocytes, and a less important role for the
selectins, which was consistent with independent experimental
findings. Furthermore, the model reasonably reproduced key
aspects of skeletal muscle ischemia and monocyte behavior,
including expected changes in hemodynamics, upregulation of
key adhesion molecules on the endothelium, enhanced secretion of
inflammatory chemokines and cytokines, and monocyte rolling
distances.
Successful ABM verification prompted a series of syste-
matic knockouts in silico aimed at identifying bottlenecks in the
Figure 2. The ABM reproduced the rapid up-regulation of CAM and increased extravasation of monocytes that is characteristic of
ischemic injury. Prior to injury at time=300, healthy endothelium maintained stable CAM expression and low monocyte extravasation. Injured
endothelium increased expression of CD54 (ICAM-1), CD106 (VCAM-1), E-selectin (CD62e), and P-selectin (CD62p) following induction of injury
(simulated by increasing pressure at sole feeder arteriole by 25%). Monocyte extravasation gradually increased (from 9% to 42%), as did the
proportion of extravasated monocytes that rolled prior. All metrics stabilized by 2,400 seconds (40 minutes; n=5–9). Reported are mean extravasated
monocytes+standard deviation. Colored lines depict endothelium CAM expression (average; lines fitted to discrete data points obtained on
10 second intervals).
doi:10.1371/journal.pcbi.1000294.g002
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necessary expression of an unknown selectin-binding molecule
(SBM-X) to achieve expected levels of hASC homing (in contrast
to circulating monocytes which were found in the simulation to be
insensitive to selectin expression). This does not unequivocally
confirm that there were not other mechanisms that would have
given this same effect in silico, had we hypothesized them (hence
the danger inherent in this type of modeling). Rather, the model
suggested that hASCs possess the capability to roll on selectins
using an un-identified adhesion molecule, in addition to any
rolling behavior mediated by CD15s, CD34, CD62p, CD65, E-
selectin, or P-selectin expressed on hASCs. Essentially, the failure
of the model prompted the formation of a novel hypothesis that we
were able to test in silico and in vitro, which illustrates the power and
flexibility of utilizing computational techniques.
The ABM presented here does not accurately reproduce all
aspects of acute skeletal muscle ischemia, nor does the rule-set
adequately account for the entirety of potential mediators of
circulating cell trafficking (e.g., hypoxia, Interleukin-4, proliferation,
vasodilation, angiogenesis). It was impractical to account for all
aspectsinsilico,andthiswasnotthe goal of thisfirst generationABM.
The goal was to develop a computational tool capable of
investigating certain aspects of circulating cell trafficking in response
to ischemia. This tool was used to generate a new hypothesis, which,
when tested in the ABM, informed future experiments. The ABM,
therefore, was valuable inthat it was able to direct future researchby
synthesizing available literature, thus instantiating our, and others’,
hypotheses.
An important part of computational research is the pairing of in
silico data with independent in vitro and/or in vivo data [33,34]. As
such, we validated the predictions of the ABM with independent in
vitro data documenting an ability of hASCs to slowly roll on P-
selectin using an adhesion molecule other than PSGL-1.
Approximately 1% of perfused cells slowly rolled at speeds as
low as 2 mm/s, although it was unclear which adhesion molecule
expressed by hASCs was mediating this interaction. Flow
cytometry data suggested that CD24, a molecule capable of
supporting the rolling of monocytes, neutrophils, and metastatic
Figure 3. The ABM reproduced increased secretion of inflammatory chemokines and cytokines by simulated endothelial cells.
Baseline secretion was relatively low and stable prior to injury at time=300. Following injury (time=360), secretion markedly increased and remained
relatively unchanged for duration. Changes in secretion of chemokines and cytokines are the aggregate result of cell interactions with each other and
their environment. SDF-1a secretion was pre-programmed and not a result of simulated injury, and no rules existed for the secretion of IL-10 or TNF-a
by endothelial cells. Reported are mean values+standard deviation (n=5).
doi:10.1371/journal.pcbi.1000294.g003
Figure 4. The ABM reproduced increased exposure of circulating monocytes to inflammatory chemokines and cytokines. Prior to
ischemic insult, circulating monocyte exposure to soluble and surface-bound chemokines was relatively low (t=300 seconds; chemokines secreted
by monocytes, ECs, tissue macrophages at baseline and WSS-induced changes). After ischemic insult and for duration of simulations (t=300–
2400 seconds), a higher percentage of monocytes encountered chemokines and cytokines, a hallmark of ischemic injury in humans. This led to
additional surveying, rolling, firm adhesion, and extravasation by circulating cells. Reported are mean values+standard deviation (n=5).
doi:10.1371/journal.pcbi.1000294.g004
ABM of Stem Cell Homing
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expression by hASCs can support rolling on P-selectin should be
verified in future inhibition studies using, for example, a parallel
plate flow chamber assay. Additionally, future generations of this
ABM should account for CD24 expression levels to determine if
this could replace the rule for SBM-X.
Figure 5. The ABM reproduced expected monocyte trafficking behavior in cellular adhesion molecule knockout experiments.
Specifically, levels of monocyte extravasation were unaffected by single selectin knockouts and only marginally affected in simulations of double-
selectin knockouts, despite decreases in rolling. Only triple-selectin knockout experiments showed a greater than 80% decrease in monocyte
extravasation, which was largely due to an inability to support rolling. Similarly, ICAM-1 knockouts significantly decreased instances of monocyte
extravasation, as expected and in agreement with independent experimental findings. Reported are mean values+standard deviation (n=5–9).
Significance asserted by comparing total monocytes extravasated (rolling and non-rolling prior) to the positive control (no knockouts) (p,0.05).
Negative controls are included for illustrative purposes only and depict monocytes extravasation in non-ischemic healthy tissue.
doi:10.1371/journal.pcbi.1000294.g005
Table 2. Verification of monocyte trafficking behavior.
Verification of Monocyte Trafficking Behavior
Metric In Silico
Independently Reported
Literature Value Citation
Extravasation (% reduction)
ICAM-1 K.O. 55% 22–30% [50–52]
E-Selectin K.O. 0.5% 30% [50]
P-Selectin K.O. 0% 0% [53]
E & P-selectin K.O. 10% 0% [54,55]
Triple selectin K.O. 78% 100% [55]
Rolling Distance (mm)
Healthy Tissue 198.5657.5 NA NA
Injured Tissue 72.6614.7 400; 270658; 30–80 [52,56,57]
Simulations of adhesion molecule knockouts produced reductions in monocyte extravasation, which were in agreement with independent studies. The average rolling
distances of monocytes were comparable to values reported in the literature for rolling monocytes in vivo. In some cases, independently reported literature values
include data derived from other leukocyte subpopulations, in vitro data, inhibition studies (not knockout), and/or skeletal muscle exercise model. A 0% reduction may
also denote non-significant changes in extravasation or firm adhesion, and/or significant increases in extravasation.
doi:10.1371/journal.pcbi.1000294.t002
ABM of Stem Cell Homing
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simulations informed experimentation that may not have been
preformed otherwise; and (2) in silico data led to a fundamentally
new understanding of hASC biology. For example, data on
adhesion molecule expression indicated hASCs do not express
PSGL-1, the main ligand for the selectins, at the protein or gene
level. It was because of this that the ability of hASCs to undergo
selectin-mediated rolling was not investigated in vitro until after
the ABM suggested otherwise, even though it was known to be
important for the trafficking of other circulating cell phenotypes.
Most importantly, however, the ABM aided our discovery of the
ability of hASCs to dynamically interact with and slowly roll on
P-selectin, an adhesion molecule preferentially expressed at sites
of injury. This could be significant to the future of injectable
hASC therapies, as it suggests molecular targeting and/or
sorting strategies to enhance hASC homing. It may also offer
evidence for why hASC homing during therapy is so inefficient
(i.e., if only ,1% of hASCs possess a required ability).
Collectively, this work illustrates how an ABM can be utilized
to inform biological experiments and produce new biological
understanding.
Materials and Methods
For a review of ABMs, please see recent reviews by Thorne et
al. [33,34]. Provided below is a broad overview of the modeling
methods that were used. However, Text S1 details the literature-
based rules, model construction, model theory, as well as contains
in-depth explanations of how the model was implemented and
how the rules were formulated. This should be referenced for
Figure 6. The ABM reproduced appropriate monocyte and hASC rolling distances in simulations of trafficking in both healthy and
ischemic tissues. Data presented as the average across all the cells in the phenotype, as well as according to whether cells eventually extravasated.
(A) In simulations of healthy microvascular networks, monocytes consistently rolled 200 mm on average. Despite similar rules governing their
behavior, hASCs rolling distances varied depending on whether that cell eventually extravasated. (B) In simulations of ischemic microvascular
networks, both monocytes and hASC rolling distances were less than levels seen in healthy networks.
doi:10.1371/journal.pcbi.1000294.g006
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problem simplification process.
Agent-Based Model of Acute Skeletal Muscle Ischemia
The ABM of therapeutic stem cell trafficking during acute
skeletal muscle ischemia was created through modification of a
previously developed ABM of monocyte trafficking in healthy
skeletal muscle microvasculature [23]. The most notable changes
were a larger microvascular network (approximately 56larger to
include more venules—the presumed site of extravasation),
additional cell types (hASCs and tissue macrophages), expanded
rules for CAM expression and chemokine and cytokine activity,
simulation of acute ischemic injury, and realistic handling of time
within the simulation space. The ABM was instituted in the
Netlogo software program [27] (version 3.1) on three workstations.
Over 150 rules obtained from independent, peer-reviewed
literature were used to govern interactions between cells and their
environment (Table 5 and Text S1). The ABM’s code is available
for download at the Peirce-Cottler laboratory website (http://
www.bme.virginia.edu/peirce).
Skeletal muscle microvascular network architectures for simu-
lations were obtained from mouse spinotrapezius tissues according
to previously established protocol [23,37]. Briefly, mouse spino-
trapezius tissues were harvested, immunolabeled, and visualized
using confocal microscopy (Nikon, Model TE200-E2 with 206
objective). Endothelial cells were identified by positive isolectin
Figure 7. The ABM generated the new hypothesis that selectin-mediated rolling via an unknown adhesion molecule was critical to
hASC trafficking. Knockouts of a theorized adhesion molecule, termed SBM-X, significantly reduced hASC extravasation versus positive control (no
knockouts). A high degree of hASCs rolled prior to extravasation into ischemic tissue, as compared to the negative controls (non-ischemic healthy
tissue). Of note, the elimination of SBM-X from rule-sets also reduced the number of extravasated hASCs that did not roll prior to firm adhesion.
Reported are mean values+standard deviation (n=5–9). Significance asserted at p,0.05.
doi:10.1371/journal.pcbi.1000294.g007
Table 3. In Silico receptor-ligand pairs and functions.
Adhesion Molecule Ligand Main Function
LFA-1 (CD11a) CD54 Firm adhesion & extravasation
MAC-1 (CD11b/CD18) CD54 Firm adhesion & extravasation
CD15s Selectins Capture & rolling
CD29/CD49d (VLA-4) CD106 Firm adhesion & extravasation
CD34 CD62L Capture, rolling, & clumping
CD54 (ICAM-1) MAC-1 Firm adhesion & extravasation
CD62E (E-selectin) CD15s, CD65, CD162, SBM-X Capture & rolling
CD62P (P-selectin) CD162, SBM-X Capture & rolling
CD62L (L-selectin) CD34, CD162, SBM-X Capture, rolling, & clumping
CD65 CD62E Capture & rolling
CD106 (VCAM-1) VLA-4 Firm adhesion & extravasation
CD162 (PSGL-1) Selectins Capture & rolling
SBM-X (theorized) Selectins Capture & rolling
Expanded rules governing selectins, including their expression, ligands, and capabilities were included.
doi:10.1371/journal.pcbi.1000294.t003
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Montages of digital images were made, and networks were then
discretized into elements (vessels) and nodes (branch-points) before
being manually inputted into the simulation space (Figure 10). In
silico vessels preserved their in vivo characteristics, which were
stored as agent variables, including vessel phenotype (arteriole,
capillary, or venule), vessel diameter, vessel-to-vessel connectivity,
and vessel length. Endothelial cell agents were simulated to be
46 mm in length (1 pixel equals 1 endothelial cell), and capillary
bed properties were conserved (,1 mm distance from feeding
arteriole to draining venule). The simulation space was discretized
into square pixels, and the simulation space was 11.02 mm
2
(4.6962.34 mm) containing 1654 endothelial cells (Table 1).
We approached the paradigm of circulating cell trafficking and
EC adhesion as being critically dependent on four general
components: receptor-ligand interactions, CAM expression, solu-
ble and surface-bound chemokines and cytokines, and hemody-
namics. We believed these simplifications were adequate for
investigations and development and institution of rules governing
these properties are outlined below. For additional clarification
and detailed explanation of individual rules, please see Text S1.
In Silico Receptor-Ligand Pairs
Types of interactions between circulating cells and the
endothelium in silico included secondary capture and rolling on
already adherent circulating cells (Figure 11). Table 3 lists
adhesion molecules and binding pairs present within the model.
Of note, there were expanded rules governing selectin binding, as
this was the primary scope of interest within the ABM. For
example, rules governing CD15s [38], CD34 [39], and CD65 [40]
expression were instituted in addition to PSGL-1 (CD162)
expression because these have been shown to facilitate selectin-
mediated rolling. PSGL-1, in silico and in vivo, is constitutively
expressed on monocytes and absent on hASCs. This molecule, or
more importantly, the ability to roll via selectins, has been
identified as critical for circulating cell homing. Because hASCs do
not express PSGL-1, we hypothesized that an additional adhesion
molecule (currently unknown) must be capable of supporting
slowly rolling on selectins, in addition to any levels supported by
CD15s, CD34, E-selectin, P-selectin, and CD65. This hypothe-
sized adhesion molecule was termed ‘‘SBM-X’’ and we assigned
identical rules to those that governed PSGL-1 behavior.
In Silico Cellular Adhesion Molecule Expression
CAM expression rules (Text S1) were formulated as the percent
probability that an individual agent (cell) within the simulated
population would be ‘‘positive’’ for, or expressing, a given
adhesion molecule. For example, a synthesis of available literature
provided a basis for the rule that 27% of therapeutically delivered
hASCs expressed CD54. This rule was applied stochastically,
through a random number generator, on an individual basis and
averaged to a CD54+ subpopulation representing ,27% of the
total population. CAM expression was dynamic and was re-
assessed at a minimum of once every time-step (1 time-step equals
1 second).
Often, multiple publications reported on hASC adhesion
molecule expression levels, while also fitting the inclusion criteria
(Text S1). In these instances, expression data were averaged to
obtain the stated rule. In contrast, the rule for hASC expression of
the simulated selectin-binding molecule (SBM-X) was theorized
with no basis in the literature. Rather, we hypothesized that
additional mechanisms to facilitate selectin-mediated rolling may
be required for hASC trafficking, and set SBM-X expression
arbitrarily at 75%.
In Silico Chemokine and Cytokine Activity
IL-1b, IL-8, IL-10, NO, SDF-1a, TNF-a, active TGF-b, and
MCP-1 were present within the simulation space. These
chemokines and cytokines have been implicated in ischemic
injuries and/or inflammation [4,5,30] (Text S1).
Chemokine and cytokine activity was simplified to consider only
connections between exposure and subsequent behaviors (change
in CAM expression, chemokines or cytokine secretion, and/or
integrin activation), in a binary manner for each chemokine or
cytokine per cell per time-step. This was because: (1) we were
concerned with tissue-level changes across large spatial and
temporal scales; and (2) data to account for detailed mechanisms
(time of secretion, time of exposure, potency, etc.) was not
available for all of the chemokines or cytokines. From examined
literature, chemokine and cytokine activity reported in vivo (both
secretion and induced changes in cellular behavior) occurred as a
function of location, concentration, time of secretion, time of
exposure, diffusion limitations, cell history, cell phenotype, and
others. All of this information was not available in the literature for
each chemokine or cytokine, making an in silico representation of
chemokine or cytokine activity this detailed impossible. However
generic ‘‘promote’’ or ‘‘inhibit’’ behavior could be deduced from
the literature. Therefore, chemokine and cytokine activity in silico
was simplified in this manner (Text S1) and the emphasis was
placed on cause-and-effect linkages between chemokine and
cytokine activity and cell behavior (Figure 12). There is precedence
for the simplification of cellular behavior in this manner for use in
computational modeling [41].
If an agent (cell) were exposed to a chemokine or cytokine in
silico, it would instantaneously either promote or inhibit a resultant
cellular behavior, independent of most of the parameters outlined
above, as long as there was evidence in the literature for the
Figure 8. hASCs slowly rolled on immobilized P-selectin in vitro
at two levels of wall shear stress in the laminar flow assay,
instituted in a parallel plate flow chamber. Reported are average
quantified speeds of rolling cells below 100 mm/s. Adhesive interactions
between hASCs and the substrate both above and below this speed
were numerous (data not shown). Each point represents a single
observed cell’s speed (gray diamonds; data pooled across 4–6
experiments). Interactions, however, were extremely rare and we
estimate that less than 1% of hASCs slowly rolled on P-selectin in the
laminar flow assay. Competitive inhibition of PSGL-1 was ineffective, as
expected (white squares), while blocking immobilized P-selectin with
competitive antibodies inhibited all rolling activity (data not shown).
Video of the adhesive interactions between hASCs and immobilized P-
selectin is available for download at the Peirce-Cottler laboratory
website (http://www.bme.virginia.edu/peirce).
doi:10.1371/journal.pcbi.1000294.g008
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phenotype, history, presence of other chemokines and cytokines,
and diffusion limitations.
Consider the following example:
‘‘Relevant literature was examined. Data reported indicate that if Cell
Type A is exposed to Chemokine A, then Cell Type A will secrete
Chemokine B. An examination of the methods reveals that only 50% of
Cell Type A will respond to Chemokine A at low concentrations, but
65% will respond at high concentrations. Furthermore, secretion of
Chemokine B by Cell Type A occurs 30 minutes after exposure to
Chemokine A, and ceases 4 hours after removal of the stimulus
(Chemokine A exposure).’’
The data from the example would be used to generate the
following rule:
‘‘If Cell Type A is exposed to Chemokine A, Chemokine B is secreted
instantaneously (at that time step). Once Chemokine A is removed,
secretion is turned off, at that time step.’’
Figure 9. Instantaneous speeds of hASCs that slowly rolled on P-selectin. (A) A fast-rolling hASC exhibited characteristic stop-and-go
behavior. (B) A slow-rolling hASC exhibited characteristic stop-and-go behavior. Both representative profiles are of hASCs rolling on P-selectin at a
wall shear stress of 0.5 dynes/cm
2. Non-rolling cells maintained relatively constant speeds (data not shown). Video is available for download on the
Peirce-Cottler laboratory website (http://www.bme.virginia.edu/peirce).
doi:10.1371/journal.pcbi.1000294.g009
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whether Cell Type A would see Chemokine A, and also a percent
probability whether Chemokine B would be subsequently secreted.
Whether an agent can become exposed to a secreted chemokine
depends, primarily, on its phenotype. For example, circulating
cells can become exposed if: (1) they come into contact with an
endothelial cell that is actively secreting that chemokine or
cytokine (through rolling or firm adhesion); (2) they firmly adhere
to or roll over an already adherent circulating cell that is actively
secreting that chemokine or cytokine; or (3) they are secreting that
chemokine or cytokine (autocrine feedback). In addition to these,
endothelial cells can become exposed if a local tissue macrophage
present in the interstitium is secreting that chemokine or cytokine.
In silico, chemokines and cytokines entered the simulation space
through four possible mechanisms: (1) baseline secretion by ECs,
macrophages, and/or circulating monocytes; (2) WSS-induced
secretion by ECs; (3) chemokine-induced secretion by ECs,
macrophages, and/or circulating monocytes; and (4) chemokine
or cytokine secretion by ECs local to a site of circulating cell
extravasation (trans-endothelial migration). The one exception was
secretion of SDF-1a by simulated endothelial cells. At each time
step, every endothelial cell in the simulation was assigned a 75%
probability of secreting the cytokine SDF-1a, which was then re-
calculated at the next time-step. The only evidence in the literature
to support this rule was that acute ischemic injuries are often
associated with hypoxia, which has been shown to upregulate EC
expression of SDF-1a [30]. Future models should account for
hypoxia explicitly, and this rule should be flagged for future
investigation.
In Silico Hemodynamics
The ABM was paired with a network flow analysis [26], as
reported previously [23], in order to calculate relevant hemody-
namic parameters. Pressures at the feeder arteriole (inlet) and five
draining venules (outlets) were assigned based on a range of
physiological values [42], which were then used along with
programmed vessel lengths, diameters, and connectivity to
calculate pressures, flow rates, and WSS within the microvascular
network (Table 1), both before and after simulated ischemic injury.
Diameters, vessel lengths, capillary bed size, and pressures were
consistent with in vivo observations and those found in literature
[43–46]. For example, in the hASC trafficking model during
ischemia, network flow was 31.3 ml/min and WSS in capillaries
averaged 0.9160.5 dynes/cm
2.
In Silico Survey Behavior
In silico, circulating hASCs surveyed their local environments
three times every time-step, or every 0.33 seconds. During the
‘‘lifetime’’ of a simulated hASC, each cell surveyed the
endothelium a minimum of nine times (assuming complete
navigation of vascular network) and at least three times in each
vessel phenotype (arteriole, capillary, and venule). It followed that
each simulated cell checked its local environment and responded
accordingly after each event (e.g., WSS-induced secretion,
chemokine-induced secretion, and change in CAM). During
rolling and firm adhesion, a simulated circulating cell surveyed
many more times; the cell still surveyed every 0.33 seconds, but
because it is moving slower than the free-stream, this translated to
much more than the minimum of 9 times in its ‘‘lifetime’’. In
theory (but never in practice), every endothelial cell could be
surveyed by each circulating cell. This, therefore, represented the
maximum, but the exact amount of surveying was dictated by
blood flow direction, WSS magnitude, integrin activation, and
whether adhesion molecules capable of supporting rolling/
adhesion continued to be expressed.
It should be noted that there was little evidence to indicate how
often survey actually occurs in vivo, or if it does at all. A more
realistic representation would be to include absolute receptor
numbers, affinity states, and binding kinetics, on a per cell basis.
This was not performed in the present generation of the ABM
Table 4. CD24 expression on hASCs is variable and may be a
function of donor and/or passage number.
CD24 Positive hASCs (%)
Donor A Donor B Donor C Donor D
P=1 – – 13.5 –
P=2 – – – 0.77
P=3 – 6.8 4.21 1.06
P=5 21.1 2.41 – 2.48
P=6 – 7.56 – –
Pooling all data, mean expression level was 6.6566.7% positive (min=0.77%,
max=21.1%). Of note, it was estimated that less than 1% of hASCs were
observed to slowly roll.
doi:10.1371/journal.pcbi.1000294.t004
Table 5. Summary and scope of computational model.
Behavior/Event Number of Rules/Notes
Cell types Four: monocytes, hASCs, ECs, macrophages
Acute ischemic injury 25% pressure increase at feeder arteriole
Location Adjacent collateral microvascular network
Tissue type Mouse spinotrapezius (skeletal muscle)
Adhesion molecule expression (baseline) 37 rules in three cell types
Adhesion molecule expression (changes) 20 rules in three cell types
Chemokine & cytokine secretion 44 rules in three cell types
Integrin activation 35 rules in three cell types
Survey behavior for circulating cells 11 rules
Population level cell behavior 7 rules in four cell types
In the ABM, agent behavior is governed by literature-based rules derived from independent experimental literature.
doi:10.1371/journal.pcbi.1000294.t005
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changes across entire populations of cells (versus individual cells).
During parameterization, however, model outputs were highly
sensitive to the frequency of surveying, although relative results
remained unchanged (data not shown). To clarify, increasing the
survey rate by a factor of ten significantly and substantially
increased the degree of both monocyte and hASC extravasation to
unrealistic levels, with and without the presence of SBM-X.
However, the relative increases in hASC extravasation following
the addition of SBM-X in all simulations (low or high survey rate)
were consistent.
When a circulating agent surveyed its local environment, it
‘‘asked’’ its neighbors whether they were secreting a chemokine
or cytokine, what adhesion molecules they were expressing, and
what the current WSS was (Figure 13). According to the
literature-based rule-sets, if the agent was expressing a comple-
mentary ligand, or possessed the ability to respond to an
Figure 10. Simulated microvascular network was modeled after mouse skeletal muscle, visualized using confocal microscopy
following harvest, using a 206objective. (A) Confocal microscopy image of mouse spinotrapezius muscle immuno-stained to visualize ECs with
BS1-lectin antibody (white). Vascular structures of interest were copied over in yellow in image processing software (ImageJ). Scale bar is 1 mm. (B)
The micrograph was manually discretized into nodes, defined as bifurcation points in the microvascular network, and the nodes were connected to
form elements. (C) Screen-shot of simulation space. Nodes and elements were manually drawn into the NetLogo simulation space to represent the
real microvascular network. Arterioles and venules were characterized on the micrograph based on vessel diameter. Smooth muscle cells are depicted
in red lining arterioles and venules. Endothelial cells are depicted in yellow, and tissue macrophages present within the interstitum of the simulation
space are depicted in blue.
doi:10.1371/journal.pcbi.1000294.g010
Figure 11. In the ABM of hASC trafficking during ischemia,
circulating cells were able to undergo complex adhesive
interactions under flow. These included secondary capture: clump-
ing, firmly adhering other circulating cells, and rolling on circulating
cells. Rolling along and firm adhesion to the endothelium is present in
this model, as well. All of these interactions are of potential importance.
doi:10.1371/journal.pcbi.1000294.g011
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initiating rolling, firm adhesion, or by doing nothing at all.
Once rolling or firm adhesion was initiated, conditions that
allowed this to occur must continue at every subsequent time-
step for this behavior to continue. For example, a sudden
increase in WSS could theoretically detach a firmly adhered
agent from the simulated endothelium. Similarly, as a slowly
rolling agent moves from one endothelial cell to its neighbor, it
must engage appropriate adhesion molecules on the new cell, or
it will detach back into the free-stream (Text S1).
In Silico Cell Concentrations
The concentration of simulated hASCs (500,000 cells/0.4 cc
PBS) was determined from literature that reported their use as an
effective therapy for the treatment of ischemia [20]. This
concentration was then diluted in the total blood volume of a
mouse, and the rate of hASC generation in silico was set to the
amount of blood volume passing through the simulated micro-
vascular network, as a function of time and volume flow rate
(assuming tail vein injection). Lung and secondary organ
entrapment was assumed to be negligible after parameterization
identified this as not being a critical parameter (varying
entrapment on the first venous pass by 0–25% yielded non-
significant differences in the degree of hASC-extravasation).
The rule for tissue macrophage density (,600 per simulation
space) was obtained from literature reporting the number of cells
in healthy mouse skeletal muscle microvasculature using immu-
nofluorescence and confocal microscopy [47,48]. Cell proliferation
was assumed to be negligible. Similarly, the number of circulating
monocytes was assumed to remain constant during ischemic
injury.
Simulation Execution
The ABM included a realistic representation of time. Each
time-step equaled one-second. At every one-second time-step,
secretion, adhesion molecule expression, integrin activation, and
cell movement (free-stream circulating cells or rolling cells) was
assessed, re-calculated, and re-assigned to agents. Each simulation
represented 40 minutes (2400 seconds) consisting of five minutes
of healthy blood flow followed by 35 minutes of ischemia.
Prior to all simulations, cells were prescribed baseline adhesion
molecule expression levels and chemokine secretion profiles, based
on the percent probabilities of action that are outlined in the rule-
sets (Text S1). The initial tissue location of macrophages was
randomly prescribed and re-seeded prior to each simulation,
which introduced additional stochasticity. In all instances, flow
through a healthy and uninjured microvascular network was
simulated for five minutes (computing time approximately
Figure 12. Complex and dynamic connections between agents exist in the ABM. Arrows indicate connections between populations of cells
and denote some combination of the following: induced secretion, changes in cellular adhesion molecule expression, and/or integrin activation.
These chemokines and cytokines have all been implicated in human ischemic injury, and all connections between cell types are based on relevant,
independent, experimental literature.
doi:10.1371/journal.pcbi.1000294.g012
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increasing the pressure in the feeder arteriole by 25% and
hemodynamic parameters (fluid flow, pressure, and WSS) were
recalculated within MATLAB. These values were then re-assigned
within the in silico network, i.v. injection of therapeutic hASCs was
simulated, and simulations were continued for an additional
35 minutes (approximately three hours of computing time). In this
way, the simulated ischemic injury is one that would be
experienced in a collateral microvascular network following acute
injury, which is the assumed site of circulating cell extravasation.
Knockout experiments were performed by manually changing
the rule-set that each cell (agent) accessed during execution. For
example, there was a rule stating that each monocyte will have a
95% probability of expressing LFA-1 (each cell performed this
calculation during creation). To interrogate the effects of
circulating monocytes that lack this adhesion molecule, this rule
would be changed to a 0% probability. Simulations conducted
include: (1) E-selectin knockout; (2) P-selectin knockout; (3) L-
selectin knockout; (4) E- and P-selectin double knockout; (5) Triple
selectin knockout; (6) SBM-X knockout; (7) ICAM-1 knockout; (8)
CD34 knockout; (9) Negative control runs where therapeutic
hASCs were delivered to healthy skeletal muscle; (10) Positive
control runs with all rules in-place.
Cell Isolation and Culture
The UVa Human Investigation Committee approved all
procedures and protocols. Adipose tissue was obtained from either
intraoperative suction lipectomy (N=4) or laboratory liposuction of
panniculectomy specimens (N=4) from 6 female and 2 unknown
patients undergoing elective surgical procedures in the Department
of Plastic Surgery at the University of Virginia (age range: 20–60;
mean age=40.75 years old). Average body mass index (BMI) was
32.4 (BMI range=22.5–43.6). hASCs were isolated from harvested
adipose tissue using methods previously described [19,22].
Figure 13. Over-simplified logic diagram of hASC decisions performed at each time-step per agent. For questions (depicted in
rectangles) to be satisfied, conditions in rule-set and probabilities of action must be met. These vary according to local conditions. Ovals depict agent
actions and signal the end of the time-step. ‘‘Survey’’ block calls the functions listed in the insert. Surveying is preformed at a minimum of each time-
step, and if WSS is not below threshold values then the cell will detach or remain in the free-stream (not shown). Not depicted either, exposure to
chemokines and/or cytokines is re-set every time-step (all agents), as is chemokine and cytokine secretion (monocyte and EC agents only). Circulating
monocytes undergo similar logic, although more complex as they have additional rules concerning chemokine and cytokine secretion,
differentiation, and changes in adhesion molecule expression. Endothelial cell agent decisions are dynamic, also. Model code should be referenced
for detailed information.
doi:10.1371/journal.pcbi.1000294.g013
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passage cells were assayed (p=3–6) following culture utilizing
expansion medium of DMEM/F12 with 10% Fetal Bovine Serum
and 1% antibiotic-antimycotic. Plating and expansion medium
consisted of DMEM/F12 with 10% Fetal Bovine Serum (FBS) and
1% antibiotic-antimycotic. Cultures were maintained at 37uC with
5% CO2 and fed three times per week. Cells were grown to
confluence after the initial plating (p=0), typically within 3–7
days. Once confluent, the adherent cells were released with
Trypsin (0.5% Trypsin-EDTA 16; Gibco; Carlsbad, CA) and then
re-plated at 2,000 cells/cm
2. These cell culture techniques have
been shown to prevent contamination with hematopoietic cells by
us [19] and others [18], as verified using flow cytometry.
In Vitro Functional Adhesion Assay
The laminar flow assay in parallel plate flow chambers was used
to verify ABM predictions, specifically to determine whether
hASCs possessed the capability to slowly roll on P-selectin under
flow conditions. Experiments were performed according to
established protocol [22]. Briefly, P-selectin (Recombinant human
CD62P Fc chimera; R & D Systems; Minneapolis, MN) was
immobilized to the substrate (polystyrene tissue culture plastic) by
diluting the protein in PBS (10 mg/ml), followed by a 3 hour
incubation at room temperature, and an overnight incubation at
4uC with 0.5% Tween 20 in PBS. hASCs (suspended in PBS;
0.1 mM Ca
2+ and Mg
2+) were then perfused over the substrate
(incorporated as the lower wall in the parallel plate flow chamber)
at WSS of either 0.5 dynes/cm
2 or 1.0 dynes/cm
2, as indicated,
and interactions were observed using an inverted phase contrast
microscope (Diaphot-TMD; Nikon, Garden City, NY) at 106
magnification. Inhibition studies were performed by either: (1)
incubating hASCs with competitive antibodies to PSGL-1 (clone
KPL-1; Abcam, Cambridge MA) for 30 minutes prior to assay; or
(2) incubating substrates with anti-P-selectin competitive antibod-
ies (10 mg/ml; monoclonal anti-human CD62p; clone G1/G1-4;
Ancell, Bayport MN) for three hours at room temperature after
immobilizing P-selectin. To rule out non-specific interactions,
negative control experiments were performed with recombinant
human IgG1 Fc (10 mg/ml; R & D systems, Minneapolis, MN)
immobilized to the substrate, as well as 0.5% Tween 20 diluted in
PBS.
Data Acquisition and Analysis during Functional
Adhesion Assay
A Kodak MotionCorder Analyzer model 1000 camera (East-
man Kodak, Motion Analysis System Division, San Diego, CA)
was used at a frame rate of 30 frames/second. A minimum of 30
rolling cells were analyzed to calculate average speeds. Cell
interactions analyzed using VirtualDub (Version 1.6.19.0; Copy-
right 1998–2007 by Avery Lee; http://www.virtualdub.org) and
Xoomer (Version 1.3; http://www.xymantix.com) software pro-
grams.
Flow Cytometry
Following trypsinization, hASCs (N=4 donors) were evaluated
for surface expression of the protein CD24 (EbBiosciences; San
Diego, CA) using flow cytometry using a Becton Dickinson FACS
Calibur (Franklin Lakes, NJ). Cell viability was greater than 98%
(Trypan Blue dye; Gibco), and a minimum of 10,000 events were
counted for each analysis, including isotype-matched controls (PE
Mouse IgG1 K isotype; Ebioscience, San Diego CA) and positive
control (HLA-ABC; Abcam, Cambridge MA).
Statistics
All statistical comparisons were made using the statistical
analysis tools provided by SigmaStat 5.0 (Systat, Inc., Point
Richmond, CA). Results are presented in the form of mean6
standard deviation, and statistical significant was asserted at
p,0.05. In terms of the reported sample sizes, ‘‘N’’ refers to the
number of individual donor patients from which hASCs were
harvested, whereas ‘‘n’’ refers to the number of independent trials
(replicates) that were run with a particular assay condition or
simulation. Raw data were tested for normality, before being
analyzed using 1-way ANOVA followed by Tukey’s t-test. Parallel
plate flow chamber studies were normalized to negative control
runs using Tween 20, with the same cell populations. Data from
knockout simulations were assessed compared to positive controls,
where all rules for ischemic injury are intact (negative controls are
included for reference only; no statistical relevance).
Supporting Information
Text S1 Detailed explanation of rule formulation and execution,
model logic, and literature-based rules.
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